We are live on ! Find out more
TTWM

TCV Trust & Wealth Management Portfolio holdings

AUM $1.32B
1-Year Est. Return 24.29%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+24.29%
3 Year Est. Return
+68.95%
5 Year Est. Return
+77.67%
10 Year Est. Return
+242.55%
AUM
$592M
AUM Growth
-$19.4M
Cap. Flow
-$8.26M
Cap. Flow %
-1.39%
Top 10 Hldgs %
32.28%
Holding
176
New
3
Increased
33
Reduced
88
Closed
8

Top Sells

Rank Stock Value
1
K
Kellanova
K
+$1.51M
2
MCD icon
McDonald's
MCD
+$1.22M
3
HRL icon
Hormel Foods
HRL
+$684K
4
HSH
HILLSHIRE BRANDS CO
HSH
+$674K
5
XOM icon
ExxonMobil
XOM
+$524K

Sector Composition

Rank Sector Weight
1 Technology 8.66%
2 Energy 8.34%
3 Consumer Staples 7.99%
4 Financials 7.99%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
26
Emerson Electric
EMR
$83.9B
$6.73M 1.14%
107,582
-85
-0.1% -$5.52K
T icon
27
AT&T
T
$159B
$6.55M 1.11%
246,048
+2,831
+1% +$75.3K
R icon
28
Ryder
R
$9.83B
$6.34M 1.07%
70,424
-388
-0.5% -$34.8K
WMT icon
29
Walmart Inc
WMT
$885B
$6.15M 1.04%
241,410
-2,736
-1% -$69.1K
PEP icon
30
PepsiCo
PEP
$190B
$6.05M 1.02%
65,046
-697
-1% -$63.6K
BDX icon
31
Becton Dickinson
BDX
$45.6B
$6.05M 1.02%
54,506
+446
+0.8% +$50.9K
AMP icon
32
Ameriprise Financial
AMP
$48.3B
$5.96M 1.01%
48,325
-1,729
-3% -$212K
MPC icon
33
Marathon Petroleum
MPC
$92.4B
$5.87M 0.99%
138,582
-5,942
-4% -$252K
CVS icon
34
CVS Health
CVS
$133B
$5.73M 0.97%
72,034
-1,610
-2% -$127K
UNH icon
35
UnitedHealth
UNH
$376B
$5.59M 0.94%
64,814
-419
-0.6% -$35.4K
IWR icon
36
iShares Russell Mid-Cap ETF
IWR
$56B
$5.12M 0.86%
129,440
+300
+0.2% +$12.1K
INTC icon
37
Intel
INTC
$455B
$5.01M 0.85%
143,776
+1,687
+1% +$57.1K
CL icon
38
Colgate-Palmolive
CL
$73.1B
$4.97M 0.84%
76,234
-575
-0.7% -$37.9K
BF.B icon
39
Brown-Forman Class B
BF.B
$13.2B
$4.96M 0.84%
171,875
INTU icon
40
Intuit
INTU
$86.5B
$4.94M 0.83%
56,332
-1,787
-3% -$148K
VNQI icon
41
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
$4.79M 0.81%
87,879
-4,673
-5% -$272K
GSK icon
42
GSK
GSK
$104B
$4.61M 0.78%
80,245
+3,821
+5% +$234K
FL
43
DELISTED
Foot Locker
FL
$4.44M 0.75%
79,836
-1,075
-1% -$56.5K
IWM icon
44
iShares Russell 2000 ETF
IWM
$80.2B
$4.38M 0.74%
40,023
-50
-0.1% -$5.72K
BHI
45
DELISTED
Baker Hughes
BHI
$4.24M 0.72%
65,162
-3,431
-5% -$239K
MCHP icon
46
Microchip Technology
MCHP
$40.3B
$4.21M 0.71%
178,360
+24,880
+16% +$595K
MAT icon
47
Mattel
MAT
$4.38B
$4.18M 0.71%
136,315
+3,395
+3% +$120K
MS icon
48
Morgan Stanley
MS
$331B
$4.04M 0.68%
116,947
-546
-0.5% -$18.2K
WM icon
49
Waste Management
WM
$90.6B
$4.04M 0.68%
85,060
+3,720
+5% +$170K
TT icon
50
Trane Technologies
TT
$100B
$3.97M 0.67%
70,386
-408
-0.6% -$24.7K

Similar funds

TCV Trust & Wealth Management's Q3 2014 Portfolio in Review

As of Q3 2014, TCV Trust & Wealth Management held 176 positions worth $592M, down 3.2% from $612M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

TCV Trust & Wealth Management's Q3 2014 filing shows 3 new, 33 increased, 88 reduced and 8 closed positions. Its largest new stake was Kinder Morgan: 43,735 shares worth $1.68M. The largest sale was Kellanova, an estimated $1.51M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Energy and Consumer Staples.

  • TCV Trust & Wealth Management's largest Q3 2014 buy was Kinder Morgan: 43,735 shares worth $1.68M.
  • TCV Trust & Wealth Management added most to TotalEnergies in Q3 2014, an estimated $648K increase.
  • TCV Trust & Wealth Management's biggest Q3 2014 reduction was Kellanova, cutting an estimated $1.51M.
  • TCV Trust & Wealth Management fully exited HILLSHIRE BRANDS CO in Q3 2014, selling an estimated $674K.
  • TCV Trust & Wealth Management's ten largest holdings make up 32% of its $592M portfolio in Q3 2014.
  • TCV Trust & Wealth Management opened 3 new positions and closed 8 in Q3 2014.
  • TCV Trust & Wealth Management's portfolio value fell 3.2% quarter-over-quarter to $592M.

Based on TCV Trust & Wealth Management's 13F filing for Q3 2014, filed 21 Oct 2014.